Profile

Kathryn M. Greven, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

108 Ratings
10 Comments
 

Kathryn M. Greven, M.D.

Professor,

Clinical Interests

Carcinoma of the Eye and Ocular Adnexa, Gynecologic Malignancies, Head and Neck Cancers, Total Body Irradiation for Bone Marrow Transplants, General Radiation Oncology, Radiation Oncology

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-3600
Department: 336-713-3600

Email: kgreven@wakehealth.edu

Insurance Accepted »

Education & Training

  • A.B., Duke University, 1979
  • M.D., WFU School of Medicine, 1983
  • Residency, North Carolina Baptist Hospita, 1987

Board Certifications

  • American Board of Radiology, Radiation Oncology

Memberships

  • Am Medical Assn
  • Am Radium Society
  • Am Soc of Clinical Oncology
  • Am Soc Of Ther Rad & Oncology
  • Forsyth-Davie-Stokes Medical S

NPI Number

  • 1972585339
Kathryn M. Greven, M.D.

Doctor Rating

4.8 out of 5

108 Ratings
10 Comments
 

Kathryn M. Greven, M.D.

Professor, Radiation Oncology
Otolaryngology

Research Interests

Endometrial Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Radiation Injuries; Head and Neck Neoplasms
More »

Contact Information

Academic: 336-713-3600 | Department: 336-713-3600

Email: kgreven@wakehealth.edu

Recent Publications

Reirradiation for second primary or recurrent cancers of the head and neck: dosimetric and outcome analysis. Garg S, Kilburn JM, Lucas JT Jr, Randolph D, Urbanic JJ, Hinson WH, Kearns WT, Porosnicu M, Greven K.. Head Neck. 2016;38(Suppl 1):E961-E969.

Retrospective analysis of cisplatin nephrotoxicity in patients with head and neck cancer receiving outpatient treatment with concurrent high-dose cisplatin and radiation therapy [abstract]. Porosnicu M, Faig J, Taylor RC, Porosnicu KAR, Murea M, Bonomi M, Greven KM.. Int J Radiat Oncol Biol Phys. 2016;94(4):908.

Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106. Greven KM, Case LD, Nycum LR, Zekan PJ, Hurd DD, Balcueva EP, Mills GM, Zon R, Flynn PJ, Biggs D, Shaw EG, Lesser G, Naughton MJ.. J Community Support Oncol. 2015;13(3):87-94.

Impact of treatment paradigm and elective nodal coverage on resection status and failure patterns in paranasal sinus tumors [abstract]. Farris M, Lucas JT Jr, Soike M, Page BR, Porosnicu M, Browne JD, McTyre E, Greven KM.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E339-E340.

The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. Lee LJ, Ratner E, Uduman M, Winter K, Boeke M, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Yu H, Parkash V, Lu L, Gaffney D, Dicker AP, Weidhaas J.. PLoS One. 2014;9(4):e94167.

The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline. Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W Jr, Yashar C, Viswanathan AN.. Pract Radiat Oncol. 2014;4(3):137-144.

Retrospective analysis of the impact of HPV status and smoking on mucositis in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemotherapy and radiotherapy. Vatca M, Lucas JT Jr, Laudadio J, D'Agostino RB, Waltonen JD, Sullivan CA, Rouchard-Plasser R, Matsangou M, Browne JD, Greven KM, Porosnicu M.. Oral Oncol. 2014;50(9):869-876.

Phase 1/2 clinical trial of re-irradiation with pemetrexed and erlotinib followed by maintenance erlotinib for recurrent and second primary squamous cell carcinoma of the head and neck (SCCHN) [abstract]. Lucas JT, Porosnicu M, Plasser R, Sullivan CA, Waltonen JD, Brown JD, Greven KM.. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S179.

Re-irradiation for second primary or recurrent cancers of the head and neck: composite dosimetric measures to evaluate dose to the carotid arteries [abstract]. Garg S, Kilburn JM, Randolph DM, Lucas JT, Urbanic JJ, Porosnicu M, Hinson WH, Kearns WT, Greven KM.. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S480-S481.

Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Rustin GJS, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, du Bois A, Kristensen G, Jakobsen A, Greven K, et al.. Int J Gynecol Cancer. 2011;21(2):419-423.

Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. Small W Jr, Winter K, Levenback C, Iyer R, Hymes SR, Jhingran A, Gaffney D, Erickson B, Greven K.. Int J Gynecol Cancer. 2011;21(7):1266-1275.

The KRAS-variant and outcome in endometrial adenocarcinoma: combined analysis of RTOG 9708 and 9905 [abstract]. Lee LJ, Winter K, Ratner E, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Weidhaas J.. Int J Radiat Oncol Biol Phys. 2010;78(3 Suppl):S402.

Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study. Saconn PA, Gee CJ, Greven CM, McCoy TP, Ekstrand KE, Greven KM.. Int J Radiat Oncol Biol Phys. 2010;78(3):844-848.

Resolving the confusion surrounding adjuvant radiation in endometrial cancer [commentary]. Greven KM.. Oncology (Williston Park). 2009;23(4):353,356.

Can serial PET/CT imaging during and after chemoradiation treatment assist in individualizing therapy for patients with squamous cell cancer of the head and neck? [abstract]. Greven K.. J Clin Oncol. 2009;27(15 Suppl):e17022.

Radiographic complete response on post treatment CT imaging eliminates the need for adjuvant neck dissection after treatment for node positive head and neck cancer. Greven KM, Williams DW III, Browne JD, McGuirt WF Sr, White DR, D'Agostino RB Jr.. Am J Clin Oncol. 2008;31(2):169-172.

Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma. Greven KM, White DR, Browne JD, Williams DW III, McGuirt WF Sr, D'Agostino RB Jr.. Am J Clin Oncol. 2008;31(3):209-212.

Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128. Zempolich K, Fuhrman C, Milash B, Flinner R, Greven K, Ryu J, Forbes A, Kerlin K, Nichols RC, Gaffney DK.. Gynecol Oncol. 2008;109(2):275-279.

Alternative dose for choroidal melanoma treated with an iodine 125 radioactive plaque: a single institution retrospective study [abstract]. Saconn PA, Greven K, Gee C, Greven C, McCoy T, Ekstrand K.. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S415-S416.

A phase II study of acute toxicity for celebrex (TM) (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Greven K.. Int J Radiat Oncol Biol Phys. 2007;67(1):104-109.

Orbital, ocular, and optic nerve tumors. Greven KM, Greven CM. In: Gunderson LL, Tepper JE, eds. Clinical radiation oncology. 2nd ed. Philadelphia: Elsevier Churchill Livingstone;2007: 613-628.

Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of radiation therapy oncology group study 0019. Lee WR, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H.. Cancer. 2007;109(8):1506-1512.

Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Small W, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K.. Int J Radiat Oncol Biol Phys. 2007;68(4):1081-1087.

Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Small W, Greven K.. Int J Radiat Oncol Biol Phys. 2007;69(1):111-117.

Extended field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of Arm 2 of RTOG 0116 [abstract]. Small W, Winter K, Levenback C, Iyer R, Hymes S, Jhingren A, Gaffney D, Erickson B, Greven K.. Int J Radiat Oncol Biol Phys. 2007;69(3 Suppl):S5-S6.

Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T.. Gynecol Oncol. 2006;103(1):155-159.

Celebrex (Celecoxib) and chemoradiation in patients with locally advanced cervical cancer. An efficacy report of RTOG 0128 [abstract]. Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Greven K.. Int J Radiat Oncol Biol Phys. 2006;66(3 Suppl):S41.

Complete clinical response on post treatment CT imaging eliminates the need for adjuvant neck dissection following treatment for node positive head and neck cancer [abstract]. Greven KM, Williams WD, Browne JD, McGuirt WF, D'Agostino R Jr.. Int J Radiat Oncol Biol Phys. 2006;66(3 Suppl):S440.

Biochemical recurrence and late toxicity following external beam radiotherapy combined with permanent source prostate brachytherapy: analysis of RTOG 0019 [abstract]. Lee W, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Greven K, Kuettel M, Sandler H.. Int J Radiat Oncol Biol Phys. 2006;66(3 Suppl):S57.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Radiation Oncology

Clinical Interests

Carcinoma of the Eye and Ocular Adnexa, Gynecologic Malignancies, Head and Neck Cancers, Total Body Irradiation for Bone Marrow Transplants, General Radiation Oncology, Radiation Oncology
Kathryn M. Greven, M.D.

Kathryn M. Greven, M.D.

Professor, Radiation Oncology
Otolaryngology

Doctor Rating

4.8 out of 5

Kathryn M. Greven, M.D.108 Ratings
10 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.9
Time CP spent with patient
4.7
Wait time at clinic
4.6



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/23/2016

Dr. Greven is my choice for any ones treatment.

4/14/2016

*Dr. Greven was super from day one - she always took her time & was NEVER in a hurry - #5. No med's. #9. Excellent.

3/30/2016

She is a wonderful professional

2/26/2016

*Dr. Greven always takes the time to explain, listens and very kind. Very reassuring.

2/23/2016

Care provided is outstanding, and I could not ask for better care, compassion and expertise.

1/23/2016

Outstanding bedside manner, all nurses have been excellent, I would highly recommmend this institution and Doctor to any person I know.

1/12/2016

It's like I am the only person there.

11/25/2015

*Dr. Greven took me through a very challenging time (neck radiation). She had her staff delivered competent and caring service through radiation and following check-ups.

10/2/2015

The dr. gave me a hug and told me everything was going to be ok.

9/24/2015

Absolutely highest remarks for each and everyone of them!

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.